Clinical trials
Phase 3 COVID-19 trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
157 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 72 |
| 2021 | 52 |
| 2022 | 18 |
| 2023 | 14 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 157 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 8 |
| Assistance Publique - Hôpitaux de Paris | 5 |
| Mansoura University | 5 |
| Chinese Academy of Medical Sciences | 4 |
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 3 |
| Genova Inc. | 3 |
| Ain Shams University | 2 |
| Azienda Ospedaliera Universitaria Integrata Verona | 2 |
| Cadila Pharnmaceuticals | 2 |
| Cairo University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 157 |
| Coronavirus Infections | 17 |
| Severe Acute Respiratory Syndrome | 9 |
| Pneumonia | 7 |
| Cytokine Release Syndrome | 5 |
| Pneumonia, Viral | 5 |
| Inflammation | 4 |
| Respiratory Distress Syndrome | 3 |
| Respiratory Tract Infections | 3 |
| Hemostatic Disorders | 2 |
Trials
Showing 1 to 25 of 157. Each trial links to its page on Pharma Observatory.
57 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.